Qinghai Chaidamu High-tech Pharmaceutical

Qinghai Chaidamu High-tech Pharmaceutical is a specialized biopharmaceutical company established in 2000 and based in the Qaidam Basin of Qinghai Province, China. The company focuses on the development, manufacturing, and commercialization of traditional Tibetan medicines and health products derived from high-altitude biological resources, most notably Rhodiola (Hong Jingtian). It holds over 18 national drug approvals (NMPA) for products targeting indications such as altitude sickness, chronic bronchitis, renal diseases, and insomnia. Operating under the flagship brand "Zhuomadan," the company integrates high-altitude herbal cultivation with GMP-certified production facilities to provide modernized plateau-health solutions. Its industrial chain includes GAP-certified planting bases and several specialized subsidiaries for manufacturing and sales.